C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma

Explore clinical trials studying C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma trial results

Active, Not Recruiting

NCT05583149

Conditions: Aggressive B-cell NHL, C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma, C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma, +27 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States

Active, Not Recruiting

NCT05263583

Conditions: Burkitt Lymphoma, C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma, C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma, +24 more
Locations: Beijing Cancer Hospital Beijing, China

Sun Yat-sen University Cancer Center Guangzhou, China

Henan Cancer Hospital Henan, China

Shanghai East Hospital Pudong, China